phenacyl phenyl sulfide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 85338 |
| CHEMBL ID | 4103995 |
| SCHEMBL ID | 1355962 |
| MeSH ID | M0135004 |
| Synonym |
|---|
| STL286552 |
| AKOS008908644 |
| nsc-608609 |
| nsc608609 |
| .alpha.-thiophenoxy-acetophenone |
| phenacyl phenyl sulfide |
| TIMTEC1_000767 |
| 16222-10-9 |
| phenyl phenacyl sulfide |
| NCGC00175140-01 |
| HMS1536C19 |
| ethanone, 1-phenyl-2-(phenylthio)- |
| 1-phenyl-2-phenylsulfanylethanone |
| 1-phenyl-2-(phenylsulfanyl)ethanone |
| 1-phenyl-2-(phenylthio)ethanone |
| a-(phenylthio)acetophenone |
| alpha-(phenylthio)acetophenone |
| SCHEMBL1355962 |
| DTXSID30167337 |
| CHEMBL4103995 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID1473377 | Inhibition of Coxsackievirus B3 C-terminal His6-tagged protease 3C expressed in Escherichia coli BL21(DE3) at 650 uM using N-Dabcyl-KTLEALFQGPPVYE-(Edans)-NH2 as substrate after 30 mins by fluorescence assay relative to control | 2018 | Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3 | Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||